Neuromuscular and COVID-19 Issues

COVID-19 and Neuromuscular Issues

Potential neuromuscular complications of COVID-19

Assessment and mitigation of COVID-19-related risk for patients with preexisting neuromuscular disease

Guidance for management of immunosuppressive and immunomodulatory therapies,

Risks of immunosuppressant/immunomodulating therapies in patients with autoimmune NMD 

Risks of treatments for COVID-19

Risks of vaccinations